Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101721303 | 10172130 | 3 | F | 2013 | 20160726 | 20140515 | 20160803 | EXP | DK-DKMA-ADR 22411968 | PHHY2014DK057093 | NOVARTIS | 53.38 | YR | F | Y | 72.00000 | KG | 20160803 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101721303 | 10172130 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG/ML, UNK | 5 | MG | 21817 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101721303 | 10172130 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101721303 | 10172130 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101721303 | 10172130 | Arthralgia | |
| 101721303 | 10172130 | Asthenia | |
| 101721303 | 10172130 | Bone pain | |
| 101721303 | 10172130 | Constipation | |
| 101721303 | 10172130 | Diarrhoea | |
| 101721303 | 10172130 | Dizziness | |
| 101721303 | 10172130 | Dyspnoea | |
| 101721303 | 10172130 | Eye pain | |
| 101721303 | 10172130 | Fatigue | |
| 101721303 | 10172130 | Fibromyalgia | |
| 101721303 | 10172130 | Gait disturbance | |
| 101721303 | 10172130 | Gastrointestinal motility disorder | |
| 101721303 | 10172130 | Gout | |
| 101721303 | 10172130 | Headache | |
| 101721303 | 10172130 | Hypoaesthesia | |
| 101721303 | 10172130 | Impaired healing | |
| 101721303 | 10172130 | Muscle spasms | |
| 101721303 | 10172130 | Musculoskeletal stiffness | |
| 101721303 | 10172130 | Pain in extremity | |
| 101721303 | 10172130 | Pelvic pain | |
| 101721303 | 10172130 | Peripheral swelling | |
| 101721303 | 10172130 | Rash | |
| 101721303 | 10172130 | Thirst |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101721303 | 10172130 | 1 | 20130923 | 20130923 | 0 |